DOI:
10.1055/s-00000131
Synfacts
LinksClose Window
References
Follmann M. * et al. Bayer AG, Wuppertal, Germany
Discovery of the Soluble Guanylate Cyclase Stimulator Vericiguat (BAY 1021189) for the Treatment of Chronic Heart Failure.
J. Med. Chem. 2017;
60: 5146-5161
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.